Twist Bioscience Corporation (NAS: TWST) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TWSTTwist Bioscience Corporation

NAS · US · Healthcare · Diagnostics & Research · twistbioscience.com

102.88USD+4.60%Mkt Cap: 6.41B $P/E: —1d ago

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Pricier

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap6.41B $

Enterprise Value6.35B $

Revenue (TTM)409.48M $

Gross Profit191.00M $

Net Income (TTM)-77.67M $

Revenue/Share6.735 USD

Last Price102.88 USD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees979

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS90184D1000

Valuation

P/E (Trailing)—

P/E (Forward)-134.78

PEG—

EV/EBITDA-57.77

EV/Revenue15.50

P/S15.65

P/B14.05

EPS (TTM)-1.32

EPS (Forward)-0.76

52W Range

23.3098% of range104.23

52W High104.23 USD

52W Low23.30 USD

Profitability

Gross Margin50.72%

Oper. Margin-34.92%

EBITDA Margin-26.82%

Profit Margin-20.63%

ROE-16.42%

ROA-12.10%

Growth

Revenue Growth19.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-47.63M $

CapEx (TTM)28.00M $

FCF Margin-14.28%

FCF Yield-0.91%

Net Debt-60.83M $

Net Debt/EBITDA0.55

Balance Sheet

Debt/Equity0.16

Current Ratio2.70

Quick Ratio2.04

Book Value/Sh7.322 USD

Cash/Share2.757 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)74.10 USD

Upside (mean)-28.0%

Target Range36.00 USD – 95.00 USD

$36.00-28.0% to mean$95.00

# Analysts10

Ownership

Shares Out.62.27M

Float55.33M

Insiders1.20%

Institutions123.83%

Short Interest

Short Ratio9.7d

Short % Float36.38%

Short % Out.28.36%

Shares Short17.66M

Short (prev mo.)16.58M

Technical

SMA 5067.22 (+53.1%)

SMA 20045.21 (+127.6%)

Beta2.21

S&P 52W Chg20.05%

Avg Vol (30d)1.86M

Avg Vol (10d)2.63M

Technical Indicators

RSI (14)79.6

MACD9.5484

MACD Signal7.7388

MACD Hist.+1.8096

BB Upper104.63 USD

BB Middle81.92 USD

BB Lower59.21 USD

BB Width55.44%

ATR (14)5.750 USD

Vol Ratio (20d)0.89x